212 related articles for article (PubMed ID: 11734186)
21. Anxiogenic effect of cholecystokinin in the dorsal periaqueductal gray.
Netto CF; Guimarães FS
Neuropsychopharmacology; 2004 Jan; 29(1):101-7. PubMed ID: 14583742
[TBL] [Abstract][Full Text] [Related]
22. Anxiogenic effects of activation of NK-1 receptors of the dorsal periaqueductal gray as assessed by the elevated plus-maze, ultrasound vocalizations and tail-flick tests.
Bassi GS; Nobre MJ; de Araújo JE; Brandão ML
Neuropeptides; 2007 Dec; 41(6):365-74. PubMed ID: 17981325
[TBL] [Abstract][Full Text] [Related]
23. Noradrenaline microinjected into the dorsal periaqueductal gray matter causes anxiolytic-like effects in rats tested in the elevated T-maze.
Estrada VB; Matsubara NK; Gomes MV; Corrêa FM; Pelosi GG
Life Sci; 2016 May; 152():94-8. PubMed ID: 26968783
[TBL] [Abstract][Full Text] [Related]
24. Microinjection of propranolol into the dorsal periaqueductal gray causes an anxiolytic effect in the elevated plus-maze antagonized by ritanserin.
Audi EA; de Oliveira RM; Graeff FG
Psychopharmacology (Berl); 1991; 105(4):553-7. PubMed ID: 1685253
[TBL] [Abstract][Full Text] [Related]
25. Effects of glycine or (+/-)-3-amino-1-hydroxy-2-pyrrolidone microinjections along the rostrocaudal axis of the dorsal periaqueductal gray matter on rats' performance in the elevated plus-maze task.
Teixeira KV; Carobrez AP
Behav Neurosci; 1999 Feb; 113(1):196-203. PubMed ID: 10197919
[TBL] [Abstract][Full Text] [Related]
26. Differential effects of cholecystokinin (CCK-8) microinjection into the ventrolateral and dorsolateral periaqueductal gray on anxiety models in Wistar rats.
Vázquez-León P; Campos-Rodríguez C; Gonzalez-Pliego C; Miranda-Páez A
Horm Behav; 2018 Nov; 106():105-111. PubMed ID: 30342011
[TBL] [Abstract][Full Text] [Related]
27. Evidence for involvement of NK₃ receptors in the anxiogenic-like effect of SP6-11(C-terminal), a metabolite of substance P, in rats evaluated in the elevated plus-maze.
Duarte FS; Duzzioni M; Leme LR; Smith Sde P; De Lima TC
Behav Brain Res; 2016 Apr; 303():168-75. PubMed ID: 26851555
[TBL] [Abstract][Full Text] [Related]
28. Anxiogenic-like effect of the NPY Y1 receptor antagonist BIBP3226 administered into the dorsal periaqueductal gray matter in rats.
Kask A; Rägo L; Harro J
Regul Pept; 1998 Sep; 75-76():255-62. PubMed ID: 9802417
[TBL] [Abstract][Full Text] [Related]
29. Implication of the 5-HT2A and 5-HT2C (but not 5HT1A) receptors located within the periaqueductal gray in the elevated plus-maze test-retest paradigm in mice.
Gomes KS; Nunes-De-Souza RL
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1261-9. PubMed ID: 19625008
[TBL] [Abstract][Full Text] [Related]
30. Blockade of histamine H2 receptors of the periaqueductal gray and inferior colliculus induces fear-like behaviors.
Santos NR; Huston JP; Brandão ML
Pharmacol Biochem Behav; 2003 Apr; 75(1):25-33. PubMed ID: 12759110
[TBL] [Abstract][Full Text] [Related]
31. Anxiolytic effect in the elevated plus-maze of the NMDA receptor antagonist AP7 microinjected into the dorsal periaqueductal grey.
Guimarães FS; Carobrez AP; De Aguiar JC; Graeff FG
Psychopharmacology (Berl); 1991; 103(1):91-4. PubMed ID: 1672463
[TBL] [Abstract][Full Text] [Related]
32. Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice.
Teixeira RM; Santos AR; Ribeiro SJ; Calixto JB; Rae GA; De Lima TC
Eur J Pharmacol; 1996 Sep; 311(1):7-14. PubMed ID: 8884230
[TBL] [Abstract][Full Text] [Related]
33. Anxiolytic effect of midazolam microinjected into the dorsal periaqueductal grey area of rats.
Russo AS; Guimarães FS; De Aguiar JC; Graeff FG
Braz J Med Biol Res; 1991; 24(6):607-9. PubMed ID: 1823278
[TBL] [Abstract][Full Text] [Related]
34. Behavioral effects of "vehicle" microinjected into the dorsal periaqueductal grey of rats tested in the elevated plus maze.
Matheus MG; de-Lacerda JC; Guimarães FS
Braz J Med Biol Res; 1997 Jan; 30(1):61-4. PubMed ID: 9222404
[TBL] [Abstract][Full Text] [Related]
35. Serotonin in the dorsal periaqueductal gray modulates inhibitory avoidance and one-way escape behaviors in the elevated T-maze.
Zanoveli JM; Nogueira RL; Zangrossi H
Eur J Pharmacol; 2003 Jul; 473(2-3):153-61. PubMed ID: 12892833
[TBL] [Abstract][Full Text] [Related]
36. Elevated T-maze evaluation of anxiety and memory effects of NMDA/glycine-B site ligands injected into the dorsal periaqueductal gray matter and the superior colliculus of rats.
Santos P; Bittencourt AS; Schenberg LC; Carobrez AP
Neuropharmacology; 2006 Aug; 51(2):203-12. PubMed ID: 16697017
[TBL] [Abstract][Full Text] [Related]
37. NMDA-coupled periaqueductal gray glycine receptors modulate anxioselective drug effects on plus-maze performance.
De Souza MM; Schenberg LC; de Pádua Carobrez A
Behav Brain Res; 1998 Feb; 90(2):157-65. PubMed ID: 9521547
[TBL] [Abstract][Full Text] [Related]
38. Anxiogenic-like effect of glycine and D-serine microinjected into dorsal periaqueductal gray matter of rats.
Schmitt ML; Coelho W; Lopes-de-Souza AS; Guimarães FS; Carobrez AP
Neurosci Lett; 1995 Apr; 189(2):93-6. PubMed ID: 7609926
[TBL] [Abstract][Full Text] [Related]
39. Substance P injected into the dorsal periaqueductal gray causes anxiogenic effects similar to the long-term isolation as assessed by ultrasound vocalizations measurements.
Bassi GS; Nobre MJ; Carvalho MC; Brandão ML
Behav Brain Res; 2007 Sep; 182(2):301-7. PubMed ID: 17208313
[TBL] [Abstract][Full Text] [Related]
40. Involvement of midbrain tectum neurokinin-mediated mechanisms in fear and anxiety.
Brenes JC; Broiz AC; Bassi GS; Schwarting RK; Brandão ML
Braz J Med Biol Res; 2012 Apr; 45(4):349-56. PubMed ID: 22392188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
